Eric van Hooren

Eric van Hooren is a seasoned professional in clinical development with extensive experience spanning over three decades. Currently serving as the Senior Director of Clinical Development at Byondis since May 2023, Eric plays a key role in defining and coordinating clinical strategies for R&D projects. Prior to this, Eric held the position of Chief Development Officer at Xenikos B.V., where responsibilities included overseeing the global clinical development of T-Guard for acute graft-versus-host disease. Eric's career also includes significant roles at Acerta Pharma, Merck, NV Organon, and AstraZeneca, contributing to the execution and management of various clinical trial programs. Eric holds a Drs degree in Biology from Radboud University and has a solid educational foundation from Gymnasium Bernrode in the Netherlands.